Jove
Visualize
Contact Us

Related Experiment Videos

Dystrophin: a clinical perspective.

H B Wessel1

  • 1Department of Pediatrics, Children's Hospital of Pittsburg, Pennsylvania 15213.

Pediatric Neurology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Dystrophin testing in muscle biopsies offers a direct biochemical diagnosis for Duchenne and Becker muscular dystrophies. This advancement aids in accurate diagnosis, carrier detection, and evaluating potential therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.

Journal of medical genetics·2009
Same author

Inability to induce fragile sites at CTG repeats in congenital myotonic dystrophy.

American journal of medical genetics·1996
Same author

Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei.

Neurology·1995
Same author

Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

American journal of human genetics·1994
Same author

Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

American journal of human genetics·1993
Same author

Diagnosis of dystrophinopathies: review for the clinician.

Pediatric neurology·1993
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Duchenne and Becker muscular dystrophies are linked to the dystrophin gene.
  • Dystrophin is a large cytoskeletal protein crucial for muscle fiber membrane integrity.
  • Animal models with dystrophin-related myopathies are valuable for studying human diseases.

Purpose of the Study:

  • To highlight the diagnostic utility of immunologic dystrophin detection in muscle biopsies.
  • To explore applications of dystrophin testing in clinical settings.
  • To emphasize the role of dystrophin identification in developing targeted therapies.

Main Methods:

  • Immunologic detection of dystrophin protein in clinical muscle biopsy samples.
  • Utilizing animal models of dystrophin-related myopathies for research.

Related Experiment Videos

Main Results:

  • Immunologic dystrophin detection serves as a direct biochemical diagnostic test for Duchenne and Becker muscular dystrophies.
  • Dystrophin testing enables improved diagnostic accuracy and various screening applications.
  • Identification of dystrophin is pivotal for advancing rational therapeutic strategies.

Conclusions:

  • Immunologic dystrophin analysis is a key diagnostic tool for muscular dystrophies.
  • Dystrophin testing has broad clinical applications, including diagnosis, carrier, and fetal testing.
  • Understanding dystrophin is crucial for the development of effective treatments for muscular dystrophies.